Hainan Honz Pharmaceutical Co Cash Flow Conversion Efficiency

Latest as of September 2025: -0.009x

Hainan Honz Pharmaceutical Co cash flow conversion efficiency. Based on the latest financial reports, Hainan Honz Pharmaceutical Co (300086) has a cash flow conversion efficiency ratio of -0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-9.17 Million ≈ $-1.34 Million USD) by net assets (CN¥1.07 Billion ≈ $157.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Hainan Honz Pharmaceutical Co (2007–2025)

Cash flow conversion efficiency of Hainan Honz Pharmaceutical Co from 2007 to 2025. This chart illustrates how Hainan Honz Pharmaceutical Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300086 stock price and chart for real-time trading data and today's change.

Hainan Honz Pharmaceutical Co Cash Flow Conversion Ratio Explained

Hainan Honz Pharmaceutical Co cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Hainan Honz Pharmaceutical Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hainan Honz Pharmaceutical Co ranked by their cash flow conversion efficiency. Also see market cap of Hainan Honz Pharmaceutical Co for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Build-A-Bear Workshop Inc NYSE:BBW	0.031x
Ercros MC:ECR	0.137x
Qingdao Daneng Environmental Protection Equipment Co Ltd SHG:688501	-0.016x
Hanyang ENG Co. Ltd KQ:045100	0.041x
Chengdu Rainbow Appliance Gr SHE:003023	-0.053x
TECHPOINT INC. JDR/1 F:R46	N/A
Beijing Sanfo Outdoor Products Co Ltd SHE:002780	-0.026x
Wonderla Holidays Limited NSE:WONDERLA	0.024x

Annual Cash Flow Conversion Efficiency for Hainan Honz Pharmaceutical Co (2007–2025)

The table below shows the annual cash flow conversion efficiency of Hainan Honz Pharmaceutical Co from 2007 to 2025. Review 300086 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥921.22 Million ≈ $134.80 Million	CN¥121.24 Million ≈ $17.74 Million	0.132x	+114.62%
2024-12-31	CN¥1.17 Billion ≈ $170.52 Million	CN¥71.46 Million ≈ $10.46 Million	0.061x	+19.53%
2023-12-31	CN¥1.38 Billion ≈ $201.65 Million	CN¥70.69 Million ≈ $10.34 Million	0.051x	+137.15%
2022-12-31	CN¥1.36 Billion ≈ $198.35 Million	CN¥29.32 Million ≈ $4.29 Million	0.022x	+196.65%
2021-12-31	CN¥1.55 Billion ≈ $227.35 Million	CN¥11.33 Million ≈ $1.66 Million	0.007x	+169.76%
2020-12-31	CN¥1.60 Billion ≈ $234.39 Million	CN¥-16.74 Million ≈ $-2.45 Million	-0.010x	-137.16%
2019-12-31	CN¥1.60 Billion ≈ $234.40 Million	CN¥45.06 Million ≈ $6.59 Million	0.028x	-70.50%
2018-12-31	CN¥1.65 Billion ≈ $241.97 Million	CN¥157.66 Million ≈ $23.07 Million	0.095x	+907.72%
2017-12-31	CN¥1.92 Billion ≈ $281.05 Million	CN¥18.17 Million ≈ $2.66 Million	0.009x	-80.51%
2016-12-31	CN¥1.87 Billion ≈ $274.03 Million	CN¥90.88 Million ≈ $13.30 Million	0.049x	+14.15%
2015-12-31	CN¥1.84 Billion ≈ $269.49 Million	CN¥78.30 Million ≈ $11.46 Million	0.043x	+3.78%
2014-12-31	CN¥1.80 Billion ≈ $264.07 Million	CN¥73.93 Million ≈ $10.82 Million	0.041x	-6.05%
2013-12-31	CN¥1.81 Billion ≈ $264.88 Million	CN¥78.93 Million ≈ $11.55 Million	0.044x	-25.37%
2012-12-31	CN¥1.87 Billion ≈ $274.16 Million	CN¥109.46 Million ≈ $16.02 Million	0.058x	+207.30%
2011-12-31	CN¥1.85 Billion ≈ $271.29 Million	CN¥-100.94 Million ≈ $-14.77 Million	-0.054x	-224.62%
2010-12-31	CN¥1.83 Billion ≈ $267.58 Million	CN¥79.89 Million ≈ $11.69 Million	0.044x	-88.77%
2009-12-31	CN¥240.49 Million ≈ $35.19 Million	CN¥93.58 Million ≈ $13.69 Million	0.389x	-6.52%
2008-12-31	CN¥150.41 Million ≈ $22.01 Million	CN¥62.61 Million ≈ $9.16 Million	0.416x	+57.69%
2007-12-31	CN¥115.89 Million ≈ $16.96 Million	CN¥30.59 Million ≈ $4.48 Million	0.264x	--

About Hainan Honz Pharmaceutical Co

SHE:300086 China Drug Manufacturers - Specialty & Generic

Market Cap

$319.01 Million

CN¥2.18 Billion CNY

Market Cap Rank

#14259 Global

#4211 in China

Share Price

CN¥4.79

Change (1 day)

+1.48%

52-Week Range

CN¥4.62 - CN¥13.71

All Time High

CN¥17.75